Skip to content
About Us
Our Mission
Leadership
Board of Directors
Careers
Contact
Our Science
Overview
Resources
Expanded Access
Pipeline
Investors
Overview
News
Events
Stock Information
Filings
Corporate Governance
FAQs
About Us
Our Mission
Leadership
Board of Directors
Careers
Contact
Our Science
Overview
Resources
Expanded Access
Pipeline
Investors
Overview
News
Events
Stock Information
Filings
Corporate Governance
FAQs
About Us
Our Mission
Leadership
Board of Directors
Careers
Contact
Our Science
Overview
Resources
Expanded Access
Pipeline
Investors
Overview
News
Events
Stock Information
Filings
Corporate Governance
FAQs
About Us
Our Mission
Leadership
Board of Directors
Careers
Contact
Our Science
Overview
Resources
Expanded Access
Pipeline
Investors
Overview
News
Events
Stock Information
Filings
Corporate Governance
FAQs
Efficacy of Function-enhanced, Re-activatable, Dual-specific CAR T cells Pre-loaded with Oncolytic Virus for Immunotherapy of High-Grade Glioma
Webb, Mason et al. Previously presented at the 2023 ASCO Annual Meeting; 2023 Jun 2-6.
Download PDF
View Resource